SlideShare una empresa de Scribd logo
1 de 12
UCSF Lean Launchpad For Life Science
and Healthcare Startups
Medical Device Track
Class 1
Value Propositions
October 2, 2013
Allan May
Chairman, Life Science Angels
amay@lifescienceangels.com
UCSF Lean Launchad - Allan May
THE CORE VALUE PROPOSITION
 A Compelling Clinical Need
 Not just a genuine, verifiable, clinical need
 There are 1000’s of clinical needs that will not support a
viable business model

 A Compelling Clinical Need is one which makes a
dramatic difference in patient outcomes, not an
incremental difference
 A Compelling Clinical Need provides the
headroom necessary to discover viable business
models
UCSF Lean Launchad - Allan May
THE CORE VALUE PROPOSITION
(cont’d))
 Clinical needs are driven from the
bottoms up, not the top down
 Who is the patient type for whom it
would be malpractice not to use your
device?

 Clinical needs are technology
agnostic
 No one cares what technology you are
using to solve their compelling clinical
need
UCSF Lean Launchad - Allan May
VALUE PROPOSITIONS CONVENTIONAL
 We used to think:


Improve clinical outcomes and charge a premium price

 Now we know:



Improve clinical outcomes and reduce price, or
Match existing outcomes and reduce price

UCSF Lean Launchad - Allan May
VALUE PROPOSITIONS –
NON-CONVENTIONAL
 There are Value Propositions Not Much Talked About:





Increase physician revenue
Shift procedures to less expensive settings or less expensive care
deliverers
Shorten hospital stays
Decrease unreimbursed hospital expenses

 Are there tensions and inconsistencies between these
concepts?


Yes!

 Do different stakeholders view Value Propositions as
having different value?


Yes!
UCSF Lean Launchad - Allan May
MEDICAL DEVICE COMPANIES
HISTORICAL PERSPECTIVE
 >90% of successful medical device exits involve
acquisitions
 Achieving cash positive operations or IPOs are
possible, BUT:



Tend to involve relatively simple products and business
models that can achieve cash breakeven but cannot
scale, or
Can scale to large, sustainable companies but require 10s of
millions of $$ to do so


Meaning there is a high risk of diluting out founders and early
investors

 So, you get to decide whether to design your
company to “flip”, go cash positive, or “swing for the
fences’
UCSF Lean Launchad - Allan May
SO VALUE PROPOSITIONS DEPEND ON THE
DECISION YOU MAKE REGARDING THE
KIND OF COMPANY YOU WANT TO BUILD
 Companies built to flip mean much
different thinking about
 Value Proposition
 Customers, etc
 BTW, acquirors hate technology that lowers prices
and are really looking to improve margins

 Regardless, you need to refine and validate
your Value Proposition for corporate
acquirors

UCSF Lean Launchad - Allan May
COST/REVENUE TO THE
PROVIDER/HOSPITAL IS THE DRIVER
 Physicians and Departments are losing
influence over hospital buying decisions
 Finance departments and technological
evaluation committees are calling the shots
 The Big Conflict is between Payors who
demand cost comes down, and existing
major strategic players who are doing
everything possible to maintain price and
margins
UCSF Lean Launchad - Allan May
Proving Cost Reduction Claims
 Every medical device startup is claiming
to reduce costs
 Cost reductions need to be definitively
proven; they will Not be assumed
 Proving claims regarding cost/outcomes is
much harder than stating them



Randomized, Double blind, Placebocontrolled, prospective studies
Very long time horizons, extremely expensive
(75% of all capital raised), and many
confounding factors

UCSF Lean Launchad - Allan May
Types of Cost Reduction Claims
 We reduce cost Day One
 We reduce cost over the patient’s hospital stay
 We reduce cost by reducing complications or rehospitalizations
 We reduce cost over the course of therapy for the
patient
 We reduce cost over the treatment of the patients
condition
 Guess Which Wins?

UCSF Lean Launchad - Allan May
GAINS, PAINS, FEATURES:
EXAMPLES OF EACH
GAINS:
 Enable physician to treat a patient group or provide a therapy not
possible today (versus another method of doing something that is
possible today –better outcomes)
 Enables physician to offer existing patients more services or to
acquire new patients with new services
 Also means some other physician loses a patient; see turf battles and
saboteur

PAINS:
 Substantially decrease adverse effects, morbidity, or hospital
readmissions

FEATURES:
 Ease of use (putz factor)
 Extent to which fits into or changes current workflow or protocols
 Impact on payment to the physician user
 Fewer steps (allows more patient throughput, ie, more income)

UCSF Lean Launchad - Allan May
UCSF Lean Launchpad For Life Science
and Healthcare Startups
Medical Device Track
Class 1
Value Propositions
October 2, 2013
Allan May
Chairman, Life Science Angels
amay@lifescienceangels.com
UCSF Lean Launchad - Allan May

Más contenido relacionado

La actualidad más candente

Haro Pharmaceutical I-Corps@NIH 121014
Haro Pharmaceutical I-Corps@NIH 121014Haro Pharmaceutical I-Corps@NIH 121014
Haro Pharmaceutical I-Corps@NIH 121014Stanford University
 
Result care lean launchpad week 1 slides v2
Result care lean launchpad week 1 slides v2Result care lean launchpad week 1 slides v2
Result care lean launchpad week 1 slides v2Stanford University
 
UCSF Life Sciences Week 2 digital health - Customer Sements
UCSF Life Sciences Week 2 digital health - Customer SementsUCSF Life Sciences Week 2 digital health - Customer Sements
UCSF Life Sciences Week 2 digital health - Customer SementsStanford University
 
Tomo Wavelabs I-Corps@NIH 121014
Tomo Wavelabs I-Corps@NIH 121014Tomo Wavelabs I-Corps@NIH 121014
Tomo Wavelabs I-Corps@NIH 121014Stanford University
 
BCN Biosciences I-corps@nih 121014
BCN Biosciences I-corps@nih 121014 BCN Biosciences I-corps@nih 121014
BCN Biosciences I-corps@nih 121014 Stanford University
 
UCSF Life Sciences Week 2 Therapeutics: Customer Segments
UCSF Life Sciences Week 2 Therapeutics: Customer SegmentsUCSF Life Sciences Week 2 Therapeutics: Customer Segments
UCSF Life Sciences Week 2 Therapeutics: Customer SegmentsStanford University
 
Orthopaedic Device Industry Business Models: 2020 and Beyond
Orthopaedic Device Industry Business Models: 2020 and BeyondOrthopaedic Device Industry Business Models: 2020 and Beyond
Orthopaedic Device Industry Business Models: 2020 and BeyondApril Bright
 
Dx1 amd week10 class presentation
Dx1 amd week10 class presentationDx1 amd week10 class presentation
Dx1 amd week10 class presentationStanford University
 
Magnamosis inc final presentation 12 10
Magnamosis inc final presentation 12 10Magnamosis inc final presentation 12 10
Magnamosis inc final presentation 12 10Stanford University
 
BioHybrid Graft I-Corps@NIH 121014
BioHybrid Graft I-Corps@NIH 121014BioHybrid Graft I-Corps@NIH 121014
BioHybrid Graft I-Corps@NIH 121014Stanford University
 
Rvex Engr245 2021 Lessons Learned
Rvex Engr245 2021 Lessons LearnedRvex Engr245 2021 Lessons Learned
Rvex Engr245 2021 Lessons LearnedStanford University
 
CRE Medical Final NSF I-Corps Presentation
CRE Medical Final NSF I-Corps PresentationCRE Medical Final NSF I-Corps Presentation
CRE Medical Final NSF I-Corps PresentationStanford University
 

La actualidad más candente (20)

Haro Pharmaceutical I-Corps@NIH 121014
Haro Pharmaceutical I-Corps@NIH 121014Haro Pharmaceutical I-Corps@NIH 121014
Haro Pharmaceutical I-Corps@NIH 121014
 
Petx I-Corps@NIH 121014
Petx I-Corps@NIH 121014Petx I-Corps@NIH 121014
Petx I-Corps@NIH 121014
 
Result care lean launchpad week 1 slides v2
Result care lean launchpad week 1 slides v2Result care lean launchpad week 1 slides v2
Result care lean launchpad week 1 slides v2
 
CardiaX I-Corps@NIH 121014
CardiaX I-Corps@NIH 121014CardiaX I-Corps@NIH 121014
CardiaX I-Corps@NIH 121014
 
UCSF Life Sciences Week 2 digital health - Customer Sements
UCSF Life Sciences Week 2 digital health - Customer SementsUCSF Life Sciences Week 2 digital health - Customer Sements
UCSF Life Sciences Week 2 digital health - Customer Sements
 
Tomo Wavelabs I-Corps@NIH 121014
Tomo Wavelabs I-Corps@NIH 121014Tomo Wavelabs I-Corps@NIH 121014
Tomo Wavelabs I-Corps@NIH 121014
 
CerviCare Columbia
CerviCare ColumbiaCerviCare Columbia
CerviCare Columbia
 
BCN Biosciences I-corps@nih 121014
BCN Biosciences I-corps@nih 121014 BCN Biosciences I-corps@nih 121014
BCN Biosciences I-corps@nih 121014
 
UCSF Life Sciences Week 2 Therapeutics: Customer Segments
UCSF Life Sciences Week 2 Therapeutics: Customer SegmentsUCSF Life Sciences Week 2 Therapeutics: Customer Segments
UCSF Life Sciences Week 2 Therapeutics: Customer Segments
 
Orthopaedic Device Industry Business Models: 2020 and Beyond
Orthopaedic Device Industry Business Models: 2020 and BeyondOrthopaedic Device Industry Business Models: 2020 and Beyond
Orthopaedic Device Industry Business Models: 2020 and Beyond
 
Dx1 amd week10 class presentation
Dx1 amd week10 class presentationDx1 amd week10 class presentation
Dx1 amd week10 class presentation
 
MedAid 2017
MedAid 2017MedAid 2017
MedAid 2017
 
Affinity I-Corps@NIH 121014
Affinity I-Corps@NIH 121014Affinity I-Corps@NIH 121014
Affinity I-Corps@NIH 121014
 
Magnamosis inc final presentation 12 10
Magnamosis inc final presentation 12 10Magnamosis inc final presentation 12 10
Magnamosis inc final presentation 12 10
 
MD Backline
MD BacklineMD Backline
MD Backline
 
Novoron I-Corps@NIH 121014
Novoron I-Corps@NIH 121014 Novoron I-Corps@NIH 121014
Novoron I-Corps@NIH 121014
 
BioHybrid Graft I-Corps@NIH 121014
BioHybrid Graft I-Corps@NIH 121014BioHybrid Graft I-Corps@NIH 121014
BioHybrid Graft I-Corps@NIH 121014
 
Rvex Engr245 2021 Lessons Learned
Rvex Engr245 2021 Lessons LearnedRvex Engr245 2021 Lessons Learned
Rvex Engr245 2021 Lessons Learned
 
CRE Medical Final NSF I-Corps Presentation
CRE Medical Final NSF I-Corps PresentationCRE Medical Final NSF I-Corps Presentation
CRE Medical Final NSF I-Corps Presentation
 
Nesher Tech I-Corps@NIH 121014
Nesher Tech I-Corps@NIH 121014Nesher Tech I-Corps@NIH 121014
Nesher Tech I-Corps@NIH 121014
 

Destacado

UCSF Life Sciences Week 1 Therapeutics
UCSF Life Sciences Week 1 TherapeuticsUCSF Life Sciences Week 1 Therapeutics
UCSF Life Sciences Week 1 TherapeuticsStanford University
 
UCSF Life Sciences Week 2 Diagnostics
UCSF Life Sciences Week 2 DiagnosticsUCSF Life Sciences Week 2 Diagnostics
UCSF Life Sciences Week 2 DiagnosticsStanford University
 
Value proposition for medical devices
Value proposition for medical devicesValue proposition for medical devices
Value proposition for medical devicesNealda Yusof
 
Mira Medicine Final Presentation
Mira Medicine Final PresentationMira Medicine Final Presentation
Mira Medicine Final PresentationStanford University
 
Final Project - InterNexus - NN Group
Final Project - InterNexus - NN GroupFinal Project - InterNexus - NN Group
Final Project - InterNexus - NN GroupAron James Miszlivetz
 
The Best Startup Investor Pitch Deck & How to Present to Angels & Venture Cap...
The Best Startup Investor Pitch Deck & How to Present to Angels & Venture Cap...The Best Startup Investor Pitch Deck & How to Present to Angels & Venture Cap...
The Best Startup Investor Pitch Deck & How to Present to Angels & Venture Cap...J. Skyler Fernandes
 
Foursquare's 1st Pitch Deck
Foursquare's 1st Pitch DeckFoursquare's 1st Pitch Deck
Foursquare's 1st Pitch DeckRami Al-Karmi
 
Linkedin Series B Pitch Deck
Linkedin Series B Pitch DeckLinkedin Series B Pitch Deck
Linkedin Series B Pitch DeckJoseph Hsieh
 
The slide deck we used to raise half a million dollars
The slide deck we used to raise half a million dollarsThe slide deck we used to raise half a million dollars
The slide deck we used to raise half a million dollarsBuffer
 

Destacado (11)

UCSF Life Sciences Week 1 Therapeutics
UCSF Life Sciences Week 1 TherapeuticsUCSF Life Sciences Week 1 Therapeutics
UCSF Life Sciences Week 1 Therapeutics
 
UCSF Life Sciences Week 2 Diagnostics
UCSF Life Sciences Week 2 DiagnosticsUCSF Life Sciences Week 2 Diagnostics
UCSF Life Sciences Week 2 Diagnostics
 
Knox final presentation
Knox final presentationKnox final presentation
Knox final presentation
 
Value proposition for medical devices
Value proposition for medical devicesValue proposition for medical devices
Value proposition for medical devices
 
Mira Medicine Final Presentation
Mira Medicine Final PresentationMira Medicine Final Presentation
Mira Medicine Final Presentation
 
Final Project - InterNexus - NN Group
Final Project - InterNexus - NN GroupFinal Project - InterNexus - NN Group
Final Project - InterNexus - NN Group
 
Team m patch aid v5 aug 31
Team m   patch aid v5 aug 31Team m   patch aid v5 aug 31
Team m patch aid v5 aug 31
 
The Best Startup Investor Pitch Deck & How to Present to Angels & Venture Cap...
The Best Startup Investor Pitch Deck & How to Present to Angels & Venture Cap...The Best Startup Investor Pitch Deck & How to Present to Angels & Venture Cap...
The Best Startup Investor Pitch Deck & How to Present to Angels & Venture Cap...
 
Foursquare's 1st Pitch Deck
Foursquare's 1st Pitch DeckFoursquare's 1st Pitch Deck
Foursquare's 1st Pitch Deck
 
Linkedin Series B Pitch Deck
Linkedin Series B Pitch DeckLinkedin Series B Pitch Deck
Linkedin Series B Pitch Deck
 
The slide deck we used to raise half a million dollars
The slide deck we used to raise half a million dollarsThe slide deck we used to raise half a million dollars
The slide deck we used to raise half a million dollars
 

Similar a UCSF Life Sciences Week 1 Devices

Medical Quality Presentation 1998
Medical Quality Presentation 1998Medical Quality Presentation 1998
Medical Quality Presentation 1998rogerstrube
 
What is clinical governance
What is clinical governance What is clinical governance
What is clinical governance Josie Winter
 
Rcm value based care presentation chicago
Rcm value based care presentation chicagoRcm value based care presentation chicago
Rcm value based care presentation chicagoCarmel Roberts
 
Excel in Health: Proposition
Excel in Health: PropositionExcel in Health: Proposition
Excel in Health: PropositionInnovation Agency
 
Sight first hospitals in present perspective a doctor’s approach
Sight first hospitals in present perspective    a doctor’s approachSight first hospitals in present perspective    a doctor’s approach
Sight first hospitals in present perspective a doctor’s approachlionsleaders
 
Pharm Mfgr Advise1998
Pharm Mfgr Advise1998Pharm Mfgr Advise1998
Pharm Mfgr Advise1998rogerstrube
 
Why Most Analytic Applications Will Never Be Able to Significantly Improve He...
Why Most Analytic Applications Will Never Be Able to Significantly Improve He...Why Most Analytic Applications Will Never Be Able to Significantly Improve He...
Why Most Analytic Applications Will Never Be Able to Significantly Improve He...Health Catalyst
 
Health IT Summit San Francisco 2015 - Keynote Presentation "Tesla or Google? ...
Health IT Summit San Francisco 2015 - Keynote Presentation "Tesla or Google? ...Health IT Summit San Francisco 2015 - Keynote Presentation "Tesla or Google? ...
Health IT Summit San Francisco 2015 - Keynote Presentation "Tesla or Google? ...Health IT Conference – iHT2
 
Excel in Health: Proposition
Excel in Health: PropositionExcel in Health: Proposition
Excel in Health: PropositionInnovation Agency
 
Maximizing efficiency and productivity in your ophthalmic practice
Maximizing efficiency and productivity in your ophthalmic practiceMaximizing efficiency and productivity in your ophthalmic practice
Maximizing efficiency and productivity in your ophthalmic practiceDr. Amani Masenya
 
ACMQ NoonConference100527
ACMQ NoonConference100527ACMQ NoonConference100527
ACMQ NoonConference100527DFetterolf
 
Lean Lessons from Three Healthcare Systems
Lean Lessons from Three Healthcare SystemsLean Lessons from Three Healthcare Systems
Lean Lessons from Three Healthcare SystemsLean Enterprise Academy
 
UCSF Life Sciences Week 5 Devices: Revenue streams
UCSF Life Sciences Week 5 Devices: Revenue streamsUCSF Life Sciences Week 5 Devices: Revenue streams
UCSF Life Sciences Week 5 Devices: Revenue streamsStanford University
 
Contemporary issues in healthcare management
Contemporary issues in healthcare managementContemporary issues in healthcare management
Contemporary issues in healthcare managementAj Raj
 
Shouldice hospital final.ppt original
Shouldice hospital final.ppt originalShouldice hospital final.ppt original
Shouldice hospital final.ppt original96540
 

Similar a UCSF Life Sciences Week 1 Devices (20)

Service analysis
Service analysisService analysis
Service analysis
 
Medical Quality Presentation 1998
Medical Quality Presentation 1998Medical Quality Presentation 1998
Medical Quality Presentation 1998
 
quality lecture
quality lecturequality lecture
quality lecture
 
What is clinical governance
What is clinical governance What is clinical governance
What is clinical governance
 
Rcm value based care presentation chicago
Rcm value based care presentation chicagoRcm value based care presentation chicago
Rcm value based care presentation chicago
 
Excel in Health: Proposition
Excel in Health: PropositionExcel in Health: Proposition
Excel in Health: Proposition
 
Sight first hospitals in present perspective a doctor’s approach
Sight first hospitals in present perspective    a doctor’s approachSight first hospitals in present perspective    a doctor’s approach
Sight first hospitals in present perspective a doctor’s approach
 
Pharm Mfgr Advise1998
Pharm Mfgr Advise1998Pharm Mfgr Advise1998
Pharm Mfgr Advise1998
 
Why Most Analytic Applications Will Never Be Able to Significantly Improve He...
Why Most Analytic Applications Will Never Be Able to Significantly Improve He...Why Most Analytic Applications Will Never Be Able to Significantly Improve He...
Why Most Analytic Applications Will Never Be Able to Significantly Improve He...
 
Health IT Summit San Francisco 2015 - Keynote Presentation "Tesla or Google? ...
Health IT Summit San Francisco 2015 - Keynote Presentation "Tesla or Google? ...Health IT Summit San Francisco 2015 - Keynote Presentation "Tesla or Google? ...
Health IT Summit San Francisco 2015 - Keynote Presentation "Tesla or Google? ...
 
Excel in Health: Proposition
Excel in Health: PropositionExcel in Health: Proposition
Excel in Health: Proposition
 
Maximizing efficiency and productivity in your ophthalmic practice
Maximizing efficiency and productivity in your ophthalmic practiceMaximizing efficiency and productivity in your ophthalmic practice
Maximizing efficiency and productivity in your ophthalmic practice
 
TCAB_AM
TCAB_AMTCAB_AM
TCAB_AM
 
Z_Final (2)
Z_Final (2)Z_Final (2)
Z_Final (2)
 
ACMQ NoonConference100527
ACMQ NoonConference100527ACMQ NoonConference100527
ACMQ NoonConference100527
 
Lean Lessons from Three Healthcare Systems
Lean Lessons from Three Healthcare SystemsLean Lessons from Three Healthcare Systems
Lean Lessons from Three Healthcare Systems
 
UCSF Life Sciences Week 5 Devices: Revenue streams
UCSF Life Sciences Week 5 Devices: Revenue streamsUCSF Life Sciences Week 5 Devices: Revenue streams
UCSF Life Sciences Week 5 Devices: Revenue streams
 
Contemporary issues in healthcare management
Contemporary issues in healthcare managementContemporary issues in healthcare management
Contemporary issues in healthcare management
 
Shouldice hospital final.ppt original
Shouldice hospital final.ppt originalShouldice hospital final.ppt original
Shouldice hospital final.ppt original
 
Lean thinking for the nhs
Lean thinking for the nhsLean thinking for the nhs
Lean thinking for the nhs
 

Más de Stanford University

Team Networks - 2022 Technology, Innovation & Great Power Competition
Team Networks  - 2022 Technology, Innovation & Great Power CompetitionTeam Networks  - 2022 Technology, Innovation & Great Power Competition
Team Networks - 2022 Technology, Innovation & Great Power CompetitionStanford University
 
Team LiOn Batteries - 2022 Technology, Innovation & Great Power Competition
Team LiOn Batteries  - 2022 Technology, Innovation & Great Power CompetitionTeam LiOn Batteries  - 2022 Technology, Innovation & Great Power Competition
Team LiOn Batteries - 2022 Technology, Innovation & Great Power CompetitionStanford University
 
Team Quantum - 2022 Technology, Innovation & Great Power Competition
Team Quantum  - 2022 Technology, Innovation & Great Power CompetitionTeam Quantum  - 2022 Technology, Innovation & Great Power Competition
Team Quantum - 2022 Technology, Innovation & Great Power CompetitionStanford University
 
Team Disinformation - 2022 Technology, Innovation & Great Power Competition
Team Disinformation  - 2022 Technology, Innovation & Great Power CompetitionTeam Disinformation  - 2022 Technology, Innovation & Great Power Competition
Team Disinformation - 2022 Technology, Innovation & Great Power CompetitionStanford University
 
Team Wargames - 2022 Technology, Innovation & Great Power Competition
Team Wargames  - 2022 Technology, Innovation & Great Power CompetitionTeam Wargames  - 2022 Technology, Innovation & Great Power Competition
Team Wargames - 2022 Technology, Innovation & Great Power CompetitionStanford University
 
Team Acquistion - 2022 Technology, Innovation & Great Power Competition
Team Acquistion  - 2022 Technology, Innovation & Great Power Competition Team Acquistion  - 2022 Technology, Innovation & Great Power Competition
Team Acquistion - 2022 Technology, Innovation & Great Power Competition Stanford University
 
Team Climate Change - 2022 Technology, Innovation & Great Power Competition
Team Climate Change - 2022 Technology, Innovation & Great Power Competition Team Climate Change - 2022 Technology, Innovation & Great Power Competition
Team Climate Change - 2022 Technology, Innovation & Great Power Competition Stanford University
 
Altuna Engr245 2022 Lessons Learned
Altuna Engr245 2022 Lessons LearnedAltuna Engr245 2022 Lessons Learned
Altuna Engr245 2022 Lessons LearnedStanford University
 
Invisa Engr245 2022 Lessons Learned
Invisa Engr245 2022 Lessons LearnedInvisa Engr245 2022 Lessons Learned
Invisa Engr245 2022 Lessons LearnedStanford University
 
ānanda Engr245 2022 Lessons Learned
ānanda Engr245 2022 Lessons Learnedānanda Engr245 2022 Lessons Learned
ānanda Engr245 2022 Lessons LearnedStanford University
 
Gordian Knot Center Roundtable w/Depty SecDef
Gordian Knot Center Roundtable w/Depty SecDef Gordian Knot Center Roundtable w/Depty SecDef
Gordian Knot Center Roundtable w/Depty SecDef Stanford University
 
Team Army venture capital - 2021 Technology, Innovation & Great Power Competi...
Team Army venture capital - 2021 Technology, Innovation & Great Power Competi...Team Army venture capital - 2021 Technology, Innovation & Great Power Competi...
Team Army venture capital - 2021 Technology, Innovation & Great Power Competi...Stanford University
 
Team Army venture capital - 2021 Technology, Innovation & Great Power Competi...
Team Army venture capital - 2021 Technology, Innovation & Great Power Competi...Team Army venture capital - 2021 Technology, Innovation & Great Power Competi...
Team Army venture capital - 2021 Technology, Innovation & Great Power Competi...Stanford University
 
Team Catena - 2021 Technology, Innovation & Great Power Competition
Team Catena - 2021 Technology, Innovation & Great Power CompetitionTeam Catena - 2021 Technology, Innovation & Great Power Competition
Team Catena - 2021 Technology, Innovation & Great Power CompetitionStanford University
 
Team Apollo - 2021 Technology, Innovation & Great Power Competition
Team Apollo - 2021 Technology, Innovation & Great Power CompetitionTeam Apollo - 2021 Technology, Innovation & Great Power Competition
Team Apollo - 2021 Technology, Innovation & Great Power CompetitionStanford University
 
Team Drone - 2021 Technology, Innovation & Great Power Competition
Team Drone - 2021 Technology, Innovation & Great Power CompetitionTeam Drone - 2021 Technology, Innovation & Great Power Competition
Team Drone - 2021 Technology, Innovation & Great Power CompetitionStanford University
 
Team Short Circuit - 2021 Technology, Innovation & Great Power Competition
Team Short Circuit - 2021 Technology, Innovation & Great Power CompetitionTeam Short Circuit - 2021 Technology, Innovation & Great Power Competition
Team Short Circuit - 2021 Technology, Innovation & Great Power CompetitionStanford University
 
Team Aurora - 2021 Technology, Innovation & Great Power Competition
Team Aurora - 2021 Technology, Innovation & Great Power CompetitionTeam Aurora - 2021 Technology, Innovation & Great Power Competition
Team Aurora - 2021 Technology, Innovation & Great Power CompetitionStanford University
 
Team Conflicted Capital Team - 2021 Technology, Innovation & Great Power Comp...
Team Conflicted Capital Team - 2021 Technology, Innovation & Great Power Comp...Team Conflicted Capital Team - 2021 Technology, Innovation & Great Power Comp...
Team Conflicted Capital Team - 2021 Technology, Innovation & Great Power Comp...Stanford University
 
Lecture 8 - Technology, Innovation and Great Power Competition - Cyber
Lecture 8 - Technology, Innovation and Great Power Competition - CyberLecture 8 - Technology, Innovation and Great Power Competition - Cyber
Lecture 8 - Technology, Innovation and Great Power Competition - CyberStanford University
 

Más de Stanford University (20)

Team Networks - 2022 Technology, Innovation & Great Power Competition
Team Networks  - 2022 Technology, Innovation & Great Power CompetitionTeam Networks  - 2022 Technology, Innovation & Great Power Competition
Team Networks - 2022 Technology, Innovation & Great Power Competition
 
Team LiOn Batteries - 2022 Technology, Innovation & Great Power Competition
Team LiOn Batteries  - 2022 Technology, Innovation & Great Power CompetitionTeam LiOn Batteries  - 2022 Technology, Innovation & Great Power Competition
Team LiOn Batteries - 2022 Technology, Innovation & Great Power Competition
 
Team Quantum - 2022 Technology, Innovation & Great Power Competition
Team Quantum  - 2022 Technology, Innovation & Great Power CompetitionTeam Quantum  - 2022 Technology, Innovation & Great Power Competition
Team Quantum - 2022 Technology, Innovation & Great Power Competition
 
Team Disinformation - 2022 Technology, Innovation & Great Power Competition
Team Disinformation  - 2022 Technology, Innovation & Great Power CompetitionTeam Disinformation  - 2022 Technology, Innovation & Great Power Competition
Team Disinformation - 2022 Technology, Innovation & Great Power Competition
 
Team Wargames - 2022 Technology, Innovation & Great Power Competition
Team Wargames  - 2022 Technology, Innovation & Great Power CompetitionTeam Wargames  - 2022 Technology, Innovation & Great Power Competition
Team Wargames - 2022 Technology, Innovation & Great Power Competition
 
Team Acquistion - 2022 Technology, Innovation & Great Power Competition
Team Acquistion  - 2022 Technology, Innovation & Great Power Competition Team Acquistion  - 2022 Technology, Innovation & Great Power Competition
Team Acquistion - 2022 Technology, Innovation & Great Power Competition
 
Team Climate Change - 2022 Technology, Innovation & Great Power Competition
Team Climate Change - 2022 Technology, Innovation & Great Power Competition Team Climate Change - 2022 Technology, Innovation & Great Power Competition
Team Climate Change - 2022 Technology, Innovation & Great Power Competition
 
Altuna Engr245 2022 Lessons Learned
Altuna Engr245 2022 Lessons LearnedAltuna Engr245 2022 Lessons Learned
Altuna Engr245 2022 Lessons Learned
 
Invisa Engr245 2022 Lessons Learned
Invisa Engr245 2022 Lessons LearnedInvisa Engr245 2022 Lessons Learned
Invisa Engr245 2022 Lessons Learned
 
ānanda Engr245 2022 Lessons Learned
ānanda Engr245 2022 Lessons Learnedānanda Engr245 2022 Lessons Learned
ānanda Engr245 2022 Lessons Learned
 
Gordian Knot Center Roundtable w/Depty SecDef
Gordian Knot Center Roundtable w/Depty SecDef Gordian Knot Center Roundtable w/Depty SecDef
Gordian Knot Center Roundtable w/Depty SecDef
 
Team Army venture capital - 2021 Technology, Innovation & Great Power Competi...
Team Army venture capital - 2021 Technology, Innovation & Great Power Competi...Team Army venture capital - 2021 Technology, Innovation & Great Power Competi...
Team Army venture capital - 2021 Technology, Innovation & Great Power Competi...
 
Team Army venture capital - 2021 Technology, Innovation & Great Power Competi...
Team Army venture capital - 2021 Technology, Innovation & Great Power Competi...Team Army venture capital - 2021 Technology, Innovation & Great Power Competi...
Team Army venture capital - 2021 Technology, Innovation & Great Power Competi...
 
Team Catena - 2021 Technology, Innovation & Great Power Competition
Team Catena - 2021 Technology, Innovation & Great Power CompetitionTeam Catena - 2021 Technology, Innovation & Great Power Competition
Team Catena - 2021 Technology, Innovation & Great Power Competition
 
Team Apollo - 2021 Technology, Innovation & Great Power Competition
Team Apollo - 2021 Technology, Innovation & Great Power CompetitionTeam Apollo - 2021 Technology, Innovation & Great Power Competition
Team Apollo - 2021 Technology, Innovation & Great Power Competition
 
Team Drone - 2021 Technology, Innovation & Great Power Competition
Team Drone - 2021 Technology, Innovation & Great Power CompetitionTeam Drone - 2021 Technology, Innovation & Great Power Competition
Team Drone - 2021 Technology, Innovation & Great Power Competition
 
Team Short Circuit - 2021 Technology, Innovation & Great Power Competition
Team Short Circuit - 2021 Technology, Innovation & Great Power CompetitionTeam Short Circuit - 2021 Technology, Innovation & Great Power Competition
Team Short Circuit - 2021 Technology, Innovation & Great Power Competition
 
Team Aurora - 2021 Technology, Innovation & Great Power Competition
Team Aurora - 2021 Technology, Innovation & Great Power CompetitionTeam Aurora - 2021 Technology, Innovation & Great Power Competition
Team Aurora - 2021 Technology, Innovation & Great Power Competition
 
Team Conflicted Capital Team - 2021 Technology, Innovation & Great Power Comp...
Team Conflicted Capital Team - 2021 Technology, Innovation & Great Power Comp...Team Conflicted Capital Team - 2021 Technology, Innovation & Great Power Comp...
Team Conflicted Capital Team - 2021 Technology, Innovation & Great Power Comp...
 
Lecture 8 - Technology, Innovation and Great Power Competition - Cyber
Lecture 8 - Technology, Innovation and Great Power Competition - CyberLecture 8 - Technology, Innovation and Great Power Competition - Cyber
Lecture 8 - Technology, Innovation and Great Power Competition - Cyber
 

Último

Accessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactAccessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactdawncurless
 
Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Celine George
 
Measures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeMeasures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeThiyagu K
 
Student login on Anyboli platform.helpin
Student login on Anyboli platform.helpinStudent login on Anyboli platform.helpin
Student login on Anyboli platform.helpinRaunakKeshri1
 
Privatization and Disinvestment - Meaning, Objectives, Advantages and Disadva...
Privatization and Disinvestment - Meaning, Objectives, Advantages and Disadva...Privatization and Disinvestment - Meaning, Objectives, Advantages and Disadva...
Privatization and Disinvestment - Meaning, Objectives, Advantages and Disadva...RKavithamani
 
Web & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdfWeb & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdfJayanti Pande
 
A Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy ReformA Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy ReformChameera Dedduwage
 
Mastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory InspectionMastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory InspectionSafetyChain Software
 
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...EduSkills OECD
 
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdfssuser54595a
 
Introduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher EducationIntroduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher Educationpboyjonauth
 
Sanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfSanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfsanyamsingh5019
 
Interactive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communicationInteractive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communicationnomboosow
 
Employee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxEmployee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxNirmalaLoungPoorunde1
 
URLs and Routing in the Odoo 17 Website App
URLs and Routing in the Odoo 17 Website AppURLs and Routing in the Odoo 17 Website App
URLs and Routing in the Odoo 17 Website AppCeline George
 
Separation of Lanthanides/ Lanthanides and Actinides
Separation of Lanthanides/ Lanthanides and ActinidesSeparation of Lanthanides/ Lanthanides and Actinides
Separation of Lanthanides/ Lanthanides and ActinidesFatimaKhan178732
 
The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13Steve Thomason
 
Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactPECB
 
Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104misteraugie
 
Arihant handbook biology for class 11 .pdf
Arihant handbook biology for class 11 .pdfArihant handbook biology for class 11 .pdf
Arihant handbook biology for class 11 .pdfchloefrazer622
 

Último (20)

Accessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactAccessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impact
 
Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17
 
Measures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeMeasures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and Mode
 
Student login on Anyboli platform.helpin
Student login on Anyboli platform.helpinStudent login on Anyboli platform.helpin
Student login on Anyboli platform.helpin
 
Privatization and Disinvestment - Meaning, Objectives, Advantages and Disadva...
Privatization and Disinvestment - Meaning, Objectives, Advantages and Disadva...Privatization and Disinvestment - Meaning, Objectives, Advantages and Disadva...
Privatization and Disinvestment - Meaning, Objectives, Advantages and Disadva...
 
Web & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdfWeb & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdf
 
A Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy ReformA Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy Reform
 
Mastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory InspectionMastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory Inspection
 
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
 
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
 
Introduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher EducationIntroduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher Education
 
Sanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfSanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdf
 
Interactive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communicationInteractive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communication
 
Employee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxEmployee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptx
 
URLs and Routing in the Odoo 17 Website App
URLs and Routing in the Odoo 17 Website AppURLs and Routing in the Odoo 17 Website App
URLs and Routing in the Odoo 17 Website App
 
Separation of Lanthanides/ Lanthanides and Actinides
Separation of Lanthanides/ Lanthanides and ActinidesSeparation of Lanthanides/ Lanthanides and Actinides
Separation of Lanthanides/ Lanthanides and Actinides
 
The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13
 
Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global Impact
 
Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104
 
Arihant handbook biology for class 11 .pdf
Arihant handbook biology for class 11 .pdfArihant handbook biology for class 11 .pdf
Arihant handbook biology for class 11 .pdf
 

UCSF Life Sciences Week 1 Devices

  • 1. UCSF Lean Launchpad For Life Science and Healthcare Startups Medical Device Track Class 1 Value Propositions October 2, 2013 Allan May Chairman, Life Science Angels amay@lifescienceangels.com UCSF Lean Launchad - Allan May
  • 2. THE CORE VALUE PROPOSITION  A Compelling Clinical Need  Not just a genuine, verifiable, clinical need  There are 1000’s of clinical needs that will not support a viable business model  A Compelling Clinical Need is one which makes a dramatic difference in patient outcomes, not an incremental difference  A Compelling Clinical Need provides the headroom necessary to discover viable business models UCSF Lean Launchad - Allan May
  • 3. THE CORE VALUE PROPOSITION (cont’d))  Clinical needs are driven from the bottoms up, not the top down  Who is the patient type for whom it would be malpractice not to use your device?  Clinical needs are technology agnostic  No one cares what technology you are using to solve their compelling clinical need UCSF Lean Launchad - Allan May
  • 4. VALUE PROPOSITIONS CONVENTIONAL  We used to think:  Improve clinical outcomes and charge a premium price  Now we know:   Improve clinical outcomes and reduce price, or Match existing outcomes and reduce price UCSF Lean Launchad - Allan May
  • 5. VALUE PROPOSITIONS – NON-CONVENTIONAL  There are Value Propositions Not Much Talked About:     Increase physician revenue Shift procedures to less expensive settings or less expensive care deliverers Shorten hospital stays Decrease unreimbursed hospital expenses  Are there tensions and inconsistencies between these concepts?  Yes!  Do different stakeholders view Value Propositions as having different value?  Yes! UCSF Lean Launchad - Allan May
  • 6. MEDICAL DEVICE COMPANIES HISTORICAL PERSPECTIVE  >90% of successful medical device exits involve acquisitions  Achieving cash positive operations or IPOs are possible, BUT:   Tend to involve relatively simple products and business models that can achieve cash breakeven but cannot scale, or Can scale to large, sustainable companies but require 10s of millions of $$ to do so  Meaning there is a high risk of diluting out founders and early investors  So, you get to decide whether to design your company to “flip”, go cash positive, or “swing for the fences’ UCSF Lean Launchad - Allan May
  • 7. SO VALUE PROPOSITIONS DEPEND ON THE DECISION YOU MAKE REGARDING THE KIND OF COMPANY YOU WANT TO BUILD  Companies built to flip mean much different thinking about  Value Proposition  Customers, etc  BTW, acquirors hate technology that lowers prices and are really looking to improve margins  Regardless, you need to refine and validate your Value Proposition for corporate acquirors UCSF Lean Launchad - Allan May
  • 8. COST/REVENUE TO THE PROVIDER/HOSPITAL IS THE DRIVER  Physicians and Departments are losing influence over hospital buying decisions  Finance departments and technological evaluation committees are calling the shots  The Big Conflict is between Payors who demand cost comes down, and existing major strategic players who are doing everything possible to maintain price and margins UCSF Lean Launchad - Allan May
  • 9. Proving Cost Reduction Claims  Every medical device startup is claiming to reduce costs  Cost reductions need to be definitively proven; they will Not be assumed  Proving claims regarding cost/outcomes is much harder than stating them   Randomized, Double blind, Placebocontrolled, prospective studies Very long time horizons, extremely expensive (75% of all capital raised), and many confounding factors UCSF Lean Launchad - Allan May
  • 10. Types of Cost Reduction Claims  We reduce cost Day One  We reduce cost over the patient’s hospital stay  We reduce cost by reducing complications or rehospitalizations  We reduce cost over the course of therapy for the patient  We reduce cost over the treatment of the patients condition  Guess Which Wins? UCSF Lean Launchad - Allan May
  • 11. GAINS, PAINS, FEATURES: EXAMPLES OF EACH GAINS:  Enable physician to treat a patient group or provide a therapy not possible today (versus another method of doing something that is possible today –better outcomes)  Enables physician to offer existing patients more services or to acquire new patients with new services  Also means some other physician loses a patient; see turf battles and saboteur PAINS:  Substantially decrease adverse effects, morbidity, or hospital readmissions FEATURES:  Ease of use (putz factor)  Extent to which fits into or changes current workflow or protocols  Impact on payment to the physician user  Fewer steps (allows more patient throughput, ie, more income) UCSF Lean Launchad - Allan May
  • 12. UCSF Lean Launchpad For Life Science and Healthcare Startups Medical Device Track Class 1 Value Propositions October 2, 2013 Allan May Chairman, Life Science Angels amay@lifescienceangels.com UCSF Lean Launchad - Allan May